The corporate-backed online pharmacy is in discussions with SoftBank over a $100m round that would potentially value it at $400m.
Telecommunications and internet group SoftBank has entered talks to lead a $100m funding round for India-based healthcare e-commerce platform PharmEasy, Livemint has reported.
Founded in 2015, PharmEasy has created an online platform that enables users to buy pharmaceutical products such as over-the-counter medicines or diagnostic tests. It also connects patients to local pharmacies and diagnostic centres.
The prospective round would value the company at approximately $400m, more than double its valuation when it last raised money in September 2018, three…
